ARCHIVES

Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants

This article is from The Cancer Letter archive.

Vol. 01 No. 02 | January 10, 1975

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson Breast Cancer Studies Promising NEJM Publishes Bonadnna Report

February 27, 1976

Gene Patterns Predict Lymphoma Response To Treatment

June 28, 2002

Nexavar Improves PFS In Phase III Trial

January 25, 2013

NCI Begins Ovarian Cancer Trial To Build Blood Samples

October 28, 2005

In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored

August 16, 1974

NCAB Gives Final Approval to New Guidelines for P01s

May 29, 1987